Evidence map›Paper›PMID 42044175›Full record

ArticlePLoS computational biology2026

A multi-omics framework for survival mediation analysis of high-dimensional proteogenomic data.

Seungjun Ahn, Weijia Fu, Maaike van Gerwen, Lei Liu, Zhigang Li

Abstract read
In one paragraph

Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Seungjun AhnDepartment of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.ORCID https://orcid.org/0000-0002-4816-8924
Weijia FuDepartment of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Maaike van GerwenDepartment of Otolaryngology - Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Lei LiuDivision of Biostatistics, Washington University in St. Louis, St. Louis, Missouri, United States of America.
Zhigang LiDepartment of Biostatistics, University of Florida, Gainesville, Florida, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Survival analysis plays a crucial role in understanding time-to-event (survival) outcomes such as disease progression. Despite recent advancements in causal mediation frameworks for survival analysis, existing methods are typically based on Cox regression and primarily focus on a single exposure or individual omics layers, often overlooking multi-omics interplay. This limitation hinders the full potential of integrated biological insights. In this paper, we propose SMAHP, a novel method for survival mediation analysis that simultaneously handles high-dimensional exposures and mediators, integrates multi-omics data, and offers a robust statistical framework for identifying causal pathways on survival outcomes. This is one of the first attempts to introduce the accelerated failure time (AFT) model within a multi-omics causal mediation framework for survival outcomes. Through simulations across multiple scenarios, we demonstrate that SMAHP achieves high statistical power, while effectively controlling false discovery rate (FDR), compared with two other approaches. We further apply SMAHP to the largest head-and-neck carcinoma proteogenomic data, detecting a gene mediated by a protein that influences survival time. R package is freely available on CRAN repository and published under General Public License version 3.

Indexed as

ProteogenomicsAlgorithmsComputational BiologyComputer SimulationHumansMultiomicsSurvival Analysis

Identifiers

PMID42044175
PMCPMC13138757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.